Android app Apple app link

Relmada Therapeutics, Inc. (RLMD) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.8
Day's range
$7.41

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
03/13/2026 Mizuho Securities Uy Ear $10.00 $5.91   69.2%
06/04/2024 Goldman Sachs Andrea Tan $2.00 $2.95   -32.2%
10/13/2022 Jefferies Andrew Tsai $8.00 $6.48   23.55%
10/13/2022 Oppenheimer Jay Olson $7.00 $6.75   3.73%

Relmada Therapeutics Inc FAQ's

Relmada Therapeutics Inc has been rated by research analysts at Mizuho Securities, Leerink Partners, Jefferies, Goldman Sachs, Oppenheimer in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.